UNSPSC 51161709: Poractant alfa

This classification denotes a respiratory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KE3U2023NP. Amiphenazole most often comes in base and hydrochloride forms. European Medicines Agency schedules Poractant Alfa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22150. As of Q4 2014, PORACTANT ALFA remains the US FDA Preferred Term for this commodity.

UNSPSC 51161709 Poractant alfa is a Commodity code intended to classify surfactant replacement therapy for respiratory distress syndrome, but the recent state and local opportunities posted under this code show no alignment with pharmaceutical procurement. The three most recent solicitations—a District Attorney's Office dog from Washington County, Oregon; athletic training services from the City of Tucson; and medical aid supplies from Tampa Fire Rescue—represent animal services, professional health services, and general first-aid consumables respectively, none of which are surfactant medications or related pharmaceutical products. State and local procurement systems appear to have misclassified these opportunities under the poractant alfa code, suggesting either data-entry error or a systematic miscoding of health and safety services into pharmaceutical taxonomy.

Given the absence of actual poractant alfa procurement activity in the recent opportunities block, this code shows no actionable procurement signal for vendors supplying pharmaceutical respiratory therapies to state and local buyers. The mismatch between code intent and posted opportunities indicates that pursuing activity under this UNSPSC category based on recent state and local RFP, RFQ, IFB, or ITB notices would not yield pharmaceutical contracting leads.